• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Professional Introduction to Rac-(4aS,8aS)-Octahydro-4a(2H)-Isoquinolinol Hydrochloride (CAS No. 81562-78-9)

Rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride, a compound with the CAS number 81562-78-9, is a significant molecule in the field of chemical and biomedical research. This compound belongs to the class of isoquinoline derivatives, which have garnered considerable attention due to their diverse pharmacological properties. The specific stereochemistry of this molecule, characterized by the configuration Rac-(4aS,8aS), makes it a subject of intense study in drug discovery and development.

The chemical structure of rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride consists of a complex framework that includes an octahydroisoquinoline core. This core structure is pivotal in determining its biological activity and interaction with biological targets. The hydrochloride salt form enhances its solubility and stability, making it more suitable for various applications in pharmaceutical research.

In recent years, there has been growing interest in isoquinoline derivatives due to their potential as scaffolds for developing new therapeutic agents. Studies have demonstrated that isoquinoline-based compounds exhibit a wide range of biological activities, including anti-inflammatory, anticancer, and antimicrobial properties. The specific stereochemistry of rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride plays a crucial role in modulating these activities.

One of the most compelling aspects of this compound is its potential in the development of novel drugs targeting neurological disorders. Isoquinoline derivatives have shown promise in preclinical studies as modulators of neurotransmitter systems. The unique structural features of rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride make it an attractive candidate for further investigation in this area. Researchers are particularly interested in its ability to interact with specific receptors and enzymes involved in neurodegenerative diseases.

Recent advancements in synthetic chemistry have enabled the efficient preparation of complex isoquinoline derivatives like rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride. These synthetic methods have not only improved the yield and purity of the compound but also allowed for the introduction of various functional groups that can enhance its biological activity. This has opened up new avenues for drug discovery and development.

The pharmacological profile of rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride has been extensively studied in vitro and in vivo. Initial studies have revealed that it exhibits significant binding affinity to certain therapeutic targets. This binding affinity is critical for the development of drugs that can effectively interact with biological systems. Additionally, the compound has shown low toxicity profiles in preliminary toxicity studies, making it a promising candidate for further clinical development.

The stereochemical configuration of rac-(4aS,8aS) is particularly important in determining the biological activity of this compound. The presence of the (4aS) and (8aS) configurations influences how the molecule interacts with biological targets at the molecular level. This stereochemical specificity is often a key factor in the efficacy and selectivity of pharmaceutical agents.

In conclusion, rac-(4aS,8aS)-octahydro-4a(2H)-isoquinolinol hydrochloride (CAS No. 81562-78-9) is a fascinating compound with significant potential in pharmaceutical research. Its unique structural features and stereochemistry make it an attractive candidate for developing new therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug discovery and development.

• 81562-77-8((4aS,8aS)-octahydroisoquinolin-4a(2H)-ol)
• 90483-13-9(3-azabicyclo[3.3.1]nonan-9-ol)
• 2721-61-1(Decahydroisoquinolin-4a-ol)
• 870889-15-9(4a(2H)-Isoquinolinol, octahydro-, (4aS)-)
• 1823245-32-4(3,4-Dimethylazepan-4-ol hydrochloride)
• 273378-21-5(4-cyclohexylpiperidin-4-ol)
• 2009013-80-1(1-(3-Piperidinyl)cyclopropanol hydrochloride)
• 860371-35-3(2,3,4,5,6,7,8,8a-octahydro-1H-isoquinolin-4a-ol;hydrochloride)
• 1003560-59-5(2-(Piperidin-3-yl)propan-2-ol hydrochloride)
• 252723-21-0(2-piperidin-3-ylpropan-2-ol)